Clin2
NCT07115173Possibly a fitNot yet recruiting

Triple therapy for h. pylori infection

Helicobacter Infection

Part of Infections clinical trials.

This study tests a three-drug combination (called triple therapy) to get rid of H. pylori, a bacteria that can cause stomach problems like ulcers and inflammation. If you have H. pylori and one of the listed stomach conditions, this treatment might help clear the infection.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
103 people
Ages
19 years to 75 years
Study type
Interventional

Who can take part

  • You must be 19 to 75 years old.
  • You have a confirmed H. pylori infection (a type of stomach bacteria).
  • You need treatment for at least one of: chronic stomach inflammation, stomach ulcer, previous early stomach cancer or polyp removal, ongoing stomach upset, low-grade stomach lymphoma, low blood platelets, iron deficiency anemia, stomach polyps, or a family history of stomach cancer.
  • You have not had previous H. pylori treatment.
  • You are not allergic to penicillin or macrolide antibiotics.
  • You agree to use effective birth control during the study (if of childbearing potential), and you are not pregnant or nursing.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07875933Not yet recruiting· Phase 3
Triple therapy for H. pylori infection

This study tests a new combination of three medicines to treat H. pylori, a stomach bacteria that can cause ulcers. If you have H. pylori and have not been treated for it before, this trial might help you get rid of the infection.

NCT06760065Not yet recruiting· Phase 3
New two-medicine approach for stubborn H. pylori infection

This study tests a simpler two-medicine treatment against a four-medicine approach for people whose first H. pylori treatment failed. It aims to see if the simpler option works just as well in clearing the infection.

NCT07285096Recruiting
New quadruple therapy for H. pylori infection

This trial tests a combination of four medications to treat H. pylori, a bacteria that can cause stomach ulcers and other issues. The goal is to see if this newer therapy works well for people who are infected.

Jinan
NCT07788053Not yet recruiting
Triple therapy for first-time H. pylori eradication

This study tests a new combination of three medications (bismuth, tetracycline, and rabeprazole) to see if it can successfully get rid of H. pylori infection on the first try. The goal is to offer a simpler and effective treatment option for people who haven't been treated for H. pylori before.

Pingtung City
NCT06349486Recruiting
Comparing new treatments for H. pylori infection

This trial compares three different medication combinations to see which works best for treating H. pylori infection. If you have H. pylori and haven't been treated yet, you may be able to join.

Kaohsiung City
NCT07606833Not yet recruiting· Phase 3
Combination therapy for helicobacter pylori infection

This trial tests a new medication combined with standard antibiotics and bismuth to treat helicobacter pylori, a bacteria that can cause stomach ulcers. It aims to see if this combination is safe and effective in clearing the infection.

Shenzhen, Guangdong

Hear when a new Helicobacter Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.